# Rising Pharma Holding, Inc. – FDA Inspection, Nov 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/rising-pharma-holding-inc/e272947f-5802-444c-bcab-7fcc8235e9bb
Source feed: FDA_Inspections

> FDA inspection 1223241 of Rising Pharma Holding, Inc., November 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223241
- Company Name: Rising Pharma Holding, Inc.
- Inspection Date: 2023-11-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)
- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/rising-pharma-holding-inc/a7ebd02e-b7f9-4c0e-b223-491379ffcd90

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c